Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 2 offerings, 4 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-232817 | Jan 26, 2015 EDGAR ↗ | Jan 25, 2016 D/A EDGAR ↗ | 1 latest Jan 25, 2016 | $830,000 | $603,144 | Other Health Care |
| 021-231585 | Jan 7, 2015 EDGAR ↗ | Jan 25, 2016 D/A EDGAR ↗ | 1 latest Jan 25, 2016 | $169,000 | $154,836 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Jan 25, 2016 D/A Other Health Care — $154,836 sold of $169,000 · 9 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Jan 25, 2016 · amends 0001627887-15-000002 ↗SEC file no. 021-231585 · accession 0001627887-16-000005 · filing 2 of 2 in this offering |
|---|
| Raise progress | $154,836 sold of $169,000 offered (92%) · $14,164 remaining · first sale Jul 1, 2014 Issuer's note: Value of cash, past and future services, and assets |
|---|
| Filing timing | Date of first sale: Jul 1, 2014 · Original Form D filed: Jan 7, 2015 (190 days after first sale) · This amendment (Form D/A) filed: Jan 25, 2016 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,498 days (12.3 years) |
|---|
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Jan 25, 2016. Most recent amendment for this offering in our index: this filing, Jan 25, 2016. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 9 total · includes 1 non-accredited investors |
|---|
| Exemption claimed | Rule 504 — smaller offerings (currently up to $10 million in 12 months); Rule 505 (repealed in 2017) — offerings up to $5 million; older filings still carry this code; Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed; Securities Act Section 4(a)(5) — sales only to accredited investors, up to $5 million, no advertising |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed 2014 · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $22,500 (est.) Issuer's note: payment to part time employee who was formerly a director and officer. |
|---|
| Signed by | Jacques Habra, President (Jan 20, 2016) |
|---|
| Changes vs previous filing | - total sold: $152,100 (Jan 7, 2015) → $154,836 (Jan 25, 2016)
- total offering: $157,100 (Jan 7, 2015) → $169,000 (Jan 25, 2016)
- remaining: $5,000 (Jan 7, 2015) → $14,164 (Jan 25, 2016)
- investors: 8 (Jan 7, 2015) → 9 (Jan 25, 2016)
- non-accredited investors (count): 0 (Jan 7, 2015) → 1 (Jan 25, 2016)
- proceeds to insiders: $11,250 (Jan 7, 2015) → $22,500 (Jan 25, 2016)
Compared with the D filed Jan 7, 2015 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $169,000. Typical range: $829,831–$9,999,998.
Investors: 9. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 25, 2016 D/A Other Health Care — $603,144 sold of $830,000 · 6 investors EDGAR ↗
| Filing | Form D/A (amendment) filed Jan 25, 2016 · amends 0001627887-15-000003 ↗SEC file no. 021-232817 · accession 0001627887-16-000004 · filing 2 of 2 in this offering |
|---|
| Raise progress | $603,144 sold of $830,000 offered (73%) · $226,856 remaining · first sale Aug 26, 2014 |
|---|
| Filing timing | Date of first sale: Aug 26, 2014 · Original Form D filed: Jan 26, 2015 (153 days after first sale) · This amendment (Form D/A) filed: Jan 25, 2016 This row is an amendment. Rule: the original Form D is generally due within 15 days after the first sale; the rule sets no deadline measured from an amendment. Dates shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,442 days (12.2 years) |
|---|
| Annual amendments | Issuer reported the offering may last more than one year. This filing is an amendment dated Jan 25, 2016. Most recent amendment for this offering in our index: this filing, Jan 25, 2016. Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 6 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 504 — smaller offerings (currently up to $10 million in 12 months); Rule 505 (repealed in 2017) — offerings up to $5 million; older filings still carry this code; Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed; Securities Act Section 4(a)(5) — sales only to accredited investors, up to $5 million, no advertising |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed 2014 · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $11,250 (est.) Issuer's note: Compensation to a former part time employee who also served as a director and officer. |
|---|
| Signed by | Jacques Habra, President (Jan 20, 2016) |
|---|
| Changes vs previous filing | - total sold: $217,500 (Jan 26, 2015) → $603,144 (Jan 25, 2016)
- total offering: $577,500 (Jan 26, 2015) → $830,000 (Jan 25, 2016)
- remaining: $360,000 (Jan 26, 2015) → $226,856 (Jan 25, 2016)
- investors: 2 (Jan 26, 2015) → 6 (Jan 25, 2016)
Compared with the D filed Jan 26, 2015 ( EDGAR ↗). Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Amendment history as filed; no conclusion is drawn. |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $830,000. Typical range: $829,831–$9,999,998.
Investors: 6. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 26, 2015 D Other Health Care — $217,500 sold of $577,500 · 2 investors EDGAR ↗
| Filing | Form D filed Jan 26, 2015SEC file no. 021-232817 · accession 0001627887-15-000003 · filing 1 of 2 in this offering |
|---|
| Raise progress | $217,500 sold of $577,500 offered (38%) · $360,000 remaining · first sale Aug 26, 2014 |
|---|
| Filing timing | Date of first sale: Aug 26, 2014 · Form D filed: Jan 26, 2015 (153 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,442 days (12.2 years) |
|---|
| Annual amendments | Issuer reported the offering may last more than one year. Most recent amendment for this offering in our index: Jan 25, 2016 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 2 total · issuer reported no non-accredited investors |
|---|
| Exemption claimed | Rule 504 — smaller offerings (currently up to $10 million in 12 months); Rule 505 (repealed in 2017) — offerings up to $5 million; older filings still carry this code; Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed; Securities Act Section 4(a)(5) — sales only to accredited investors, up to $5 million, no advertising |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity; Option, warrant or other right to acquire; Security to be acquired upon exercise |
|---|
| Entity details | Organized in DELAWARE · formed 2014 · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $11,250 (est.) Issuer's note: Compensation to a part time employee who also serves as a director and officer |
|---|
| Signed by | Jacques Habra, President (Jan 23, 2015) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $577,500. Typical range: $829,831–$9,999,998.
Investors: 2. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Jan 7, 2015 D Other Health Care — $152,100 sold of $157,100 · 8 investors EDGAR ↗
| Filing | Form D filed Jan 7, 2015SEC file no. 021-231585 · accession 0001627887-15-000002 · filing 1 of 2 in this offering |
|---|
| Raise progress | $152,100 sold of $157,100 offered (97%) · $5,000 remaining · first sale Jul 1, 2014 Issuer's note: Value of cash, past and future services, and assets |
|---|
| Filing timing | Date of first sale: Jul 1, 2014 · Form D filed: Jan 7, 2015 (190 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
|---|
| Time since first sale | 4,498 days (12.3 years) |
|---|
| Annual amendments | Issuer reported the offering may last more than one year. Most recent amendment for this offering in our index: Jan 25, 2016 (EDGAR ↗). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
|---|
| Investors | 8 total · includes 0 non-accredited investors |
|---|
| Exemption claimed | Rule 504 — smaller offerings (currently up to $10 million in 12 months); Rule 505 (repealed in 2017) — offerings up to $5 million; older filings still carry this code; Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed; Securities Act Section 4(a)(5) — sales only to accredited investors, up to $5 million, no advertising |
|---|
| Minimum investment accepted | $0 as filed (no minimum reported) |
|---|
| Securities offered | Equity · business combination transaction |
|---|
| Entity details | Organized in DELAWARE · formed 2014 · revenue range: No Revenues (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
|---|
| Industry | Other Health Care |
|---|
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
|---|
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $11,250 (est.) Issuer's note: Compensation to a part time employee who also serves as a director and officer |
|---|
| Signed by | Jacques Habra, President (Jan 5, 2015) |
|---|
| Market context | Minimum investment: $0 as filed (no minimum reported). Typical range for similar offerings: $10,000–$54,310.
Offering size: $157,100. Typical range: $829,831–$9,999,998.
Investors: 8. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
|---|
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
|---|
Amendment history — 2 amendments on this page, each compared with the filing before it in the same offering
| Amendment filed | File no. | Compared with | What changed (both values as filed) |
|---|
| Jan 25, 2016 EDGAR ↗ | 021-231585 | Jan 7, 2015 D | total sold: $152,100 (Jan 7, 2015) → $154,836 (Jan 25, 2016) · total offering: $157,100 (Jan 7, 2015) → $169,000 (Jan 25, 2016) · remaining: $5,000 (Jan 7, 2015) → $14,164 (Jan 25, 2016) · and 3 more (open the filing above) |
| Jan 25, 2016 EDGAR ↗ | 021-232817 | Jan 26, 2015 D | total sold: $217,500 (Jan 26, 2015) → $603,144 (Jan 25, 2016) · total offering: $577,500 (Jan 26, 2015) → $830,000 (Jan 25, 2016) · remaining: $360,000 (Jan 26, 2015) → $226,856 (Jan 25, 2016) · and 1 more (open the filing above) |
Fields compared: total sold, total offering, remaining, investors, non-accredited investors (count), non-accredited investors reported, minimum investment, sales commissions, finder's fees, proceeds to insiders, date of first sale, industry, fund type, exemption, revenue range, net asset value range, securities offered, may last more than one year, related persons, sales-compensation recipients. Values as filed; no conclusion is drawn.
All Form D filings for this CIK on SEC EDGAR ↗. History: 0 new offerings in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Jan 25, 2016. Industry as reported, by offering: All 2 offerings reported: Other Health Care (2015).
Key people 3
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| DW Daniel Wetmore | Executive Officer, Director Issuer's note: Former director and executive officer | CA | Jan 7, 2015 → Jan 25, 2016 on 4 of 4 filings listed on the latest filing | — |
| JH Jacques Habra | Executive Officer, Director | CA | Jan 7, 2015 → Jan 25, 2016 on 4 of 4 filings listed on the latest filing | — |
| SG Shelly Gable | Director, Executive Officer | CA | Jan 7, 2015 → Jan 25, 2016 on 4 of 4 filings listed on the latest filing | — |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Connections
No other issuers in our index list the same related persons. Searched: related-person listings on every Form D filing in our index, 2008 → Oct 22, 2026.
Shared address: this business address appears on filings for 1 other issuer. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched SelfEcho, Inc.
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for SelfEcho, Inc as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in SelfEcho, Inc's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #293,289 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for CA yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.